The capillary electrophoresis market has seen considerable growth due to a variety of factors.
• The value of the capillary electrophoresis market has seen substantial growth recently and is projected to increase from $0.55 $ billion in 2024 to $0.58 $ billion in 2025, at a compound annual growth rate (CAGR) of 6.5%.
Factors such as heightened demand for DNA sequencing, expansion in pharmaceutical research and development, escalating applications in biotechnology, growing academic research and the advancement of clinical diagnostics have all contributed to the growth during the historical period.
The capillary electrophoresis market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the capillary electrophoresis market is forecasted to experience robust growth, reaching $0.74 billion in 2029 with a 6.2% of compound annual growth rate (CAGR). This projected growth in the forecast period is due to several factors including the proliferation of personalized medicine, an increase in proteomics research, a growing demand for drug discovery, healthcare investment expansion, and the broadening of genomics research. Anticipated trends during this forecast period include the integration of automation, device miniaturization, a surge in applications for microfluidics, an enhanced uptake of high-throughput screening, and an increased application in the field of forensic science.
The surge in infectious diseases is anticipated to fuel the expansion of the capillary electrophoresis market. These diseases, triggered by microorganisms like bacteria, viruses, fungi or parasites, are communicable from person to person. The increase in cases arises from factors such as augmented global travel, urbanization, climate shifts, antibiotic resistance, and changes in human conduct and healthcare protocols. Capillary electrophoresis is employed in detecting and characterizing pathogens in infectious diseases swiftly by separating nucleic acids and proteins. This aids in the exact identification of infections. For example, the UK Health Security Agency reported in October 2023 that the number of HIV diagnoses in England rose by 22%, from 3,118 cases in 2021 to 3,805 in 2022. This increase is largely due to a 69% rise in diagnoses amongst individuals previously diagnosed overseas, which climbed from 805 in 2021 to 1,361 in 2022. Consequently, the escalating prevalence of infectious diseases is predicted to stimulate the growth of the capillary electrophoresis market.
The capillary electrophoresismarket covered in this report is segmented –
1) By Product Type: Instrument, Consumables, Software, Automatic Capillary Electrophoresis Systems, Semi-Automatic Capillary Electrophoresis Systems
2) By Mode: Capillary Zone Electrophoresis, Capillary Gel Electrophoresis, Capillary Electrochromatography
3) By Application: Nucleic Acid Analysis, Protein Analysis, Genomic Deoxyribonucleic Acid (DNA), Plasmid Deoxyribonucleic Acid (DNA), Fragment Analysis, Ribonucleic Acid (RNA) Or Messenger RNA (mRNA) Analysis, Other Applications
4) By End User: Research Organizations And Institutions, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Forensic Centers, Other End Users
Subsegments:
1) By Instrument: Capillary Electrophoresis Instruments, High-Performance Capillary Electrophoresis (HPCE) Systems
2) By Consumables: Capillary Tubes, Buffer Solutions, Sample Vials, Electrodes
3) By Software: Data Analysis Software, Instrument Control Software, Application-Specific Software
4) By Automatic Capillary Electrophoresis Systems: Fully Automated Systems for Routine Analysis, High-Throughput Automatic Systems
5) By Semi-Automatic Capillary Electrophoresis Systems: Systems with Manual Sample Loading, Semi-Automated Data Processing Systems
Leading organizations in the capillary electrophoresis market are prioritizing the creation of sophisticated products like automatic parallel capillary electrophoresis systems. These enhancements aim to improve effectiveness, quickness, and precision in sample examination. The mentioned systems represent state-of-the-art tools that carry out multiple sample analyses at once using capillary electrophoresis, boosting efficiency and productivity in biomolecule separation and analysis. For instance, Agilent Technologies Inc., an American firm supplying various laboratory materials, launched the ProteoAnalyzer in January 2024. This automatic parallel capillary electrophoresis system is engineered to make the examination of intricate protein mixtures easier. The ProteoAnalyzer is vital for industries including pharmaceuticals, biotechnology, food inspection, and education. By automatizing separation, data manipulation, and making sample preparation more straightforward, the ProteoAnalyzer system enhances workflow effectiveness and minimizes labor costs related to training and operations. It can deal with a broad range of sample kinds, from crude lysates to refined fractions, and can examine various sizes and kinds of proteins all at once.
Major companies operating in the capillary electrophoresis market are:
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Merck KGaA
• Danaher Corporation
• Hitachi High-Tech Corporation
• Shimadzu Corporation
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Bio-Techne Corporation
• Helena Laboratories Corporation
• Promega Corporation
• Takara Bio Inc.
• Sebia Group
• 4Basebio PLC
• BiOptic Inc.
• Major Science Co. Ltd.
• Lumex Instruments
• SERVA Electrophoresis GmbH
• LABGENE Scientific SA
• Cleaver Scientific Ltd.
North America was the largest region in the capillary electrophoresis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the capillary electrophoresis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.